Research Article Open Access Double-Blind Peer Review

OPTIMIZING TREATMENT FOR CEREBROVASCULAR ACCIDENTS: PHARMACOTHERAPEUTIC APPROACHES IN THE MEDICAL INTENSIVE CARE UNIT AT THE ABIDJAN CARDIOLOGY INSTITUTE

Jeanne Marie Kouassi
Published 27 June 2024
Vol. 1, No. 1 (2024)
pp. 55-68
CC BY 4.0
  1. 1
    Jeanne Marie Kouassi
    Laboratory of Pharmacology, Clinical and Therapeutic Pharmacy, Côte d’Ivoire and Abidjan Heart Institute of Pharmacy, Côte d’Ivoire.
    CI

Cerebrovascular accidents (CVAs), commonly known as strokes or "brain attacks," represent acute medical emergencies characterized by the obstruction or rupture of cerebral arteries, leading to the deprivation of blood supply to specific brain regions, resulting in cerebral infarction. These incidents manifest as rapid-onset neurological deficits lasting more than 24 hours, encompassing a spectrum of symptoms indicative of brain dysfunction. Among the most prevalent manifestations are sudden onset weakness or sensory loss in facial and limb muscles, typically unilateral, along with cognitive impairments such as confusion and difficulty in speech or comprehension. Visual disturbances, gait disturbances, dizziness, severe headaches, and loss of consciousness may also occur, underscoring the diverse clinical presentations associated with CVAs (Sagui, 2007; Kemnang et al., 2019).

JournalColumbia Journal of Health Education and Nursing
ISSN2998-8179
Volume / IssueVol. 1, No. 1 (2024)
Pages55-68
Published27 June 2024
Access Open Access
LicenseCC BY 4.0 — reuse with attribution
PublisherKeith Publications
Kouassi , J. (2024). OPTIMIZING TREATMENT FOR CEREBROVASCULAR ACCIDENTS: PHARMACOTHERAPEUTIC APPROACHES IN THE MEDICAL INTENSIVE CARE UNIT AT THE ABIDJAN CARDIOLOGY INSTITUTE. Columbia Journal of Health Education and Nursing, Vol. 1 No. 1, pp. 55-68

 Submit Your Research to Columbia Journal of Health Education and Nursing

We invite original research articles, review papers, and case studies. Benefit from rigorous double-blind peer review, rapid decision within 4–8 weeks, DOI for every article, and worldwide open-access distribution.